|
Match
|
Document |
Document Title |
|
|
7595341 |
Analogues of lipid mediators derived from ω-3 PUFAs and methods of use
The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ω-3; EPA], but with a longer tissue...
|
|
|
7585856 |
Resolvins: Biotemplates for novel therapeutic interventions
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
|
|
|
7560591 |
Benzamidine derivatives having anti-inflammatory and immunosuppressive activity
Compounds which can be represented by the general formula (I) indicated below:
and in which:
A is selected independently from the carboxamide group, the thiocarboxamide group, and the...
|
|
|
7557247 |
Crystalline form of β2 adrenergic receptor agonist
The invention provides a novel β 2 adrenergic receptor agonist in crystalline salt form. The invention also provides pharmaceutical compositions comprising the novel β 2 adrenergic receptor...
|
|
|
7518017 |
Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds
Methods of preparing compounds of formula (I):
wherein Y, Y 1 , and R 2 are defined herein; methods of making D-(threo)-1-aryl-2-acylamido-1-propanol compounds,...
|
|
|
7482378 |
Physiological cooling compositions
The present invention provides, in one aspect, a physiological cooling composition comprising at least one cyclohexane carboxamide, at least one acyclic carboxamide, and at least one stereoisomer...
|
|
|
7439394 |
Cyclohexyl-1,4-diamine compounds
Novel cyclohexyl-1,4-diamine compounds corresponding to formula I,
processes for the production thereof, pharmaceutical compositions containing these compounds, methods of producing...
|
|
|
7432302 |
Composition containing polyamine transport inhibitor and use thereof
Proliferative cutaneous disease states or conditions are treated by administering a polyamine transport inhibitor
|
|
|
7419972 |
2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
The invention relates to new 2-substituted estra-1,3,5(10)-trien-17-ones of formula I
as well as their pharmaceutically acceptable salts, their methods of manufacture and use as medicaments for...
|
|
|
7411091 |
N-acyl-N′-benzyl-alkylendiamino derivatives
This invention is related to compounds and use of N-Acyl-N′-benzyl-alkylendiamino derivatives of the following general formula (I), wherein A is a straight or branched C 2 -C 8 alkyl chain; X is...
|
|
|
7402697 |
Antibacterial agents
D-(threo)-1-aryl-2-disubstitutedacylamido-3-fluoro-1-propano
l compounds compounds and analogues thereof (“Fenicol Compounds”), compositions comprising an effective amount of a Fenicol...
|
|
|
7381416 |
Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics
The purpose of this invention is:
new selenohydroxy acid compounds and their derivatives; their process for the preparation; use of the new compounds as precursors of L(+)-selenomethionine...
|
|
|
RE40360 |
Methods for inhibition of angiogenesis with a composition comprising 3-hydroxythalidomide
The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs,...
|
|
|
7378446 |
Compound having anti-HCV activity and process for producing the same
The object of the present invention is to provide a compound useful for the prevention and treatment of viral infectious diseases, and particularly liver diseases caused by HCV infection due to its...
|
|
|
7378444 |
Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ω-3; EPA], but with a longer tissue...
|
|
|
7304092 |
Compounds and methods for treating tumors, cancer and hyperproliferative diseases
The present invention relates to novel compounds, pharmaceutical compositions and methods for treating tumors, cancer and hyperproliferative diseases including psoriasis, genital warts and...
|
|
|
7230018 |
Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
Substituted propane-1,3-diamine derivatives, methods for producing such derivatives, and medicaments and pharmaceutical compositions containing such derivatives useful for the treatment or...
|
|
|
7208528 |
Polyamine analogues as therapeutic and diagnostic agents
Novel inhibitors of polyamine transport having inhibition constants two orders of magnitude lower than those of known compounds are disclosed. These polyamine analogues are useful pharmaceutical...
|
|
|
7205261 |
Use of certain N-acylethanolamines to achieve ethylene- and cytokinin-like effects in plants and fungi
N-acylethanolamines (NAEs) that can deliver an ethylene- or cytokinin-like effect to a plant, plant part or fungus are disclosed. Also disclosed are methods of using the NAEs.
|
|
|
7160334 |
Composition for bleaching human hair
A water-free composition for the bleaching and brightening of human hair at the same time with a simultaneous conditioning effect is disclosed. The particularly exceptional effects of the bleaching...
|
|
|
7144897 |
Hydroxy alkyl amines
Disclosed are compounds of formula X,
which are useful in treating Alzheimer's disease and other similar diseases. Pharmaceutical compositions comprising compounds of formula X and methods of...
|
|
|
7115624 |
Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48
The present invention provides a method of inhibiting a member of a family of Protein Tyrosine Phosphatases (PTPases, PTPs) such as PTP1B, TC-PTP, CD45, SHP-1, SHP-2, PTPα, PTPε, PTPμ, PTPδ,...
|
|
|
7108867 |
Process for preparing particles
A process for preparing particles of a substance, such as a protein or polypeptide, comprising: (a) preparing a first liquid comprising water, the substance and a modulator, wherein the modulator...
|
|
|
7034058 |
Anti-tumor pharmaceutical composition comprising N-vanillyl fatty acid amide
The present invention provides an anti-tumor pharmaceutical composition having a high anti-tumor effect with low side-effects. The anti-tumor pharmaceutical composition comprises a N-vanillyl fatty...
|
|
|
6969732 |
Propylisopropyl acetic acid and propylisopropyl acetamide stereoisomers, a method for their synthesis and pharmaceutical compositions containing them
The present invention relates to racemic propylisopropyl acetic acid and propylisopropyl acetamide and their isomers in their racemic and stereospecific forms, for use in treatment of neurological...
|
|
|
RE38761 |
Styryl compounds which inhibit EGF receptor protein tyrosine kinase
A method of inhibiting cell proliferation in a patient suffering from such disorder comprising administering to said patient an effective amount of a composition comprising, in admixture with a...
|
|
|
6864285 |
Covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids functionally active on the CB2 cannabinoid receptor
The present invention relates to novel covalent derivatives of alkanolamides of monocarboxylic and dicarboxylic acids with aminoalcohols of general formula (I) which can usefully be used as...
|
|
|
6767925 |
Sprayable analgesic composition and method of use
A sprayable analgesic composition containing an analgesic which is absorbed into the bloodstream through the buccal mucosa and a pharmacologically acceptable liquid carrier.
|
|
|
6734204 |
Serotonin potentiation by oleamide analogs
Analogs related to oleamide are employed for potentiating the 5-HT 2A and 5-HT 1A responses to serotonin (5-HT). With respect to the potentiation of the 5-HT 2A receptor response, it is...
|
|
|
6706761 |
Dyed compositions containing insecticides
The invention relates to insecticide-comprising polymer-based compositions which, in order to recognize the point in time when the insecticide is exhausted, comprise at least one dye which, after...
|
|
|
6696494 |
α-hydroxyarylbutanamine inhibitors of aspartyl protease
Acylated α-hydroxyarylbutanamines and related sulfonamides, ureas and carbamates that inhibit aspartyl protease are disclosed, as are methods of treating diseases, particularly HIV, using these...
|
|
|
6689399 |
Transdermal delivery of an anti-inflammatory composition
The present invention provides an anti-inflammatory composition for treatment of joint and muscle pain through transdermnal delivery of a capsacinoid in conjunction with glucosamine. The...
|
|
|
6685953 |
External preparation compositions
The present invention relates to a dermatologic preparation containing a diamide derivative represented by the following formula (1): (wherein, R 1 represents a linear or branched hydrocarbon...
|
|
|
6677359 |
N-substituted glycine derivatives
The present invention relates N-substituted glycine derivatives for treating or preventing neuronal damage associated with neurological diseases. The invention also provides compositions comprising...
|
|
|
6656972 |
Control of pain with endogenous cannabinoids
Novel pharmaceutical therapeutic compositions and methods for using same for the treatment of pain experienced by an individual are provided. The compositions contain at least one member selected...
|
|
|
6656458 |
Poly-aminoacid derivatives and their use in compositions for treating keratinous fibres
The invention concerns the use in a cosmetic composition of at least a poly-aminoacid of general formula (1) in which X is —O—, —S— or —NR 3 ; R 1 represents in particular a hydrogen...
|
|
|
6646011 |
Insect repellant compositions
The present invention relates to insect repellant compositions containing, based upon the total weight of the composition, from about 6 to about 30 percent by weight of insect repellant active...
|
|
|
6623723 |
Method for treating bronchial constriction and bronchospasm
The present invention is directed to a method for treating bronchial constriction in mammals. The method comprises contacting mammalian lung with a compound selected from the group consisting of...
|
|
|
6599941 |
Insecticide and insect repellant compositions
A non-toxic, environmentally safe and easily employable insecticide and insect repellent is achieved by providing an aqueous composition incorporating ethanolamine based compounds, either...
|
|
|
6573297 |
(2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same
A (2-substituted oxyphenyl)alkanamide derivative or a salt thereof expressed by the following Formula (I): wherein one of A and B is a hydrocarbon group of C 3-30 expressed by R 1 and the...
|
|
|
6548550 |
Pharmaceutical compositions containing N-palmitoylethanolamide and use thereof in the veterinary field
The present invention relates to a method for treating eosinophilic granuloma in a Feline comprising administering a pharmaceutical composition, the composition comprising N-palmitoylethanolamide....
|
|
|
6548534 |
Nonsteroidal gestagens
This invention describes the new, nonsteroidal gestagens of general formula I in which A, B, Ar 1 , R 1 , R 2 and R 3 have the meanings that are indicated in more detail in the description....
|
|
|
6506733 |
Compounds and compositions as protease inhibitors
Compounds of the formula: are provided, and are useful as cysteine protease inhibitors, particularly in the treatment of diseases such as osteoporosis or autoimmune disorders in which cathepsins...
|
|
|
6492426 |
Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder
The subject invention provides a method of treating mania in bipolar disorder in a subject comprising administering to the subject a therapeutically effective amount of derivatives of 1-aminoindan...
|
|
|
6436996 |
Modulation of nitric oxide production
A method of treating cells that carry at least one APOE4 allele comprises increasing nitric oxide levels in the cells (e.g., by administering an exogenous source of nitric oxide to the cells) by an...
|
|
|
6420429 |
Brain targeted low molecular weight hydrophobic antioxidant compounds
Novel brain targeted low molecular weight, hydrophobic antioxidants and use of antioxidants in treatment of central nervous system neurodegenerative disorders such as Parkinson's, Alzheimer's and...
|
|
|
6410597 |
Hydroxyalkyl amide analogs of ceramide
The present invention provides methods for treating disease conditions associated with abnormal cellular proliferation, inflammation and viral infection or proliferation by the administration of...
|
|
|
6359010 |
Methods of treating anxiety and mood disorders with oleamide
A method of treating conditions characterized by anxiety and/or depression, by the administration of oleamide or related compounds is disclosed.
|
|
|
6359009 |
Substituted anilide insecticidal agents
Pesticidal substituted anilide compounds having the structural formula I and compositions and methods comprising those compounds for the control of insect pests.
|
|
|
6359006 |
Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications
New fluorinated derivatives useful as surfactants or in the transport of drug or markers, or in drug targeting, and preparations containing the derivatives, for medical, cosmetic and veterinary...
|